Who We Are

FASEB is a federation of scientific societies that advances health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy and service to our societies and their members.


Learn More

Policy and Advocacy

Our expansive relationships, shared global knowledge, and deep resources produce powerful science policy results for our member societies. 

Learn More


1106HP
Science Policy Priorities
Research Funding Data
Policy Statements

The FASEB Journal

View All
Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor November 16 View Research
Competitive modulation of KV1.2 gating by LMAN2 and Slc7a5 December 11
Damayantee Das, Shawn M. Lamothe, Anson A. Wong, Victoria A. Baronas, Harley T. Kurata
MiR‐21 suppression in macrophages promotes M2‐like polarization and attenuates kidney ischemia–reperfusion injury December 11
Xiaoyan Wang, Ting Ren, Xinni Zhang, Tianyi Pan, Fangyuan Peng, Jinghan Feng, Qian Sun, NaNa Song, Xiaoqiang Ding, Ping Jia
PFKFB3 protein in adipose tissue contributes to whole body glucose homeostasis December 11
Beth A. Griesel, Ann Louise Olson

Upcoming Events

View All Events
FASEB-18-Phosphatases-1440x485-Hero
Science Research Conference
Protein Phosphatases December 8-12, 2024
Member Meetings
ASBMB Deuel Conference on Lipids January 21-24, 2025
Member Meetings
2025 ABRF Annual Meeting March 23-26, 2025
Member Meetings
O-GlcNAcylation in Health and Disease July 10-13, 2025
Member Meetings
The 15th International Symposium on Proteomics in the Life Sciences August 17-21, 2025

FASEB Conferences On-Demand

GET ACCESS NOW 

Nuclear Bodies
Endoplasmic Reticulum
Hematologic Malignancies
Ubiquitin and Ub-like Proteins

Latest News

View All News
FASEB Announcements FASEB President Reaffirms Role as Collective Policy Voice November 18
FASEB President Beth Garvy reaffirms FASEB’s commitment to focus on science policy and advocacy following the 2024 election results.  
View Story
FASEB Journals News Advancement in Fetal Growth Research: Potential Therapy Reverses Placental Development Issues in Mice December 03
Scientists have discovered how a specific change to mRNA can cause problems with placenta development, leading to fetal growth restriction (FGR). In mice, a drug called STM2457 was able to reverse these effects, offering hope for future treatments.
Diversity and Inclusion FASEB Announces First Cohort of MOSAIC Scholars December 02
FASEB selects its inaugural cohort for NIH's MOSAIC program, which helps postdoctoral and new investigators from diverse backgrounds transition to independent faculty careers at research institutions. 
Federal Agency Updates Inside (the Beltway) Scoop November 20
President-elect Donald Trump will assume office in January 2025. FASEB hosts a post-election event to discuss the upcoming 119th Congress and its impact on science policy.